Showing results (251-260 of 266) with videos related to
Sort By:
Pageof 27
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.Nature Communications|June 27, 2024
Distributable, metabolic PET reporting of tuberculosisR M Naseer Khan, Yong-Mo Ahn, Gwendolyn A Marriner, et al.Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.Cell|November 3, 2018
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic DesignYin Yao Dong, Hua Wang, Ashley C W Pike, et al.The Lancet. Respiratory Medicine|March 26, 2026
PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort studyHanif Esmail, Friedrich Thienemann, Bianca Sossen, et al.ACS Infectious Diseases|December 7, 2019
Setting Our Sights on Infectious DiseasesManu De Rycker, David Horn, Bree Aldridge, et al.Journal of Medicinal Chemistry|November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification StudiesColin R Wilson, Richard K Gessner, Atica Moosa, et al.ACS Infectious Diseases|February 22, 2022
Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.Pageof 27